By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


INC Research, Inc. 

Global Headquarters
4700 Falls of Neuse Road, Suite 400
Raleigh  North Carolina  27609  U.S.A.
Phone: 919-876-9300 or 866-462-7373 Fax: 919-876-9360

For over two decades, INC Research® has been providing therapeutically focused drug development services to customers around the globe. As a specialized Contract Research Organization (CRO) we're fully dedicated to managing programs for pharmaceutical and biotech companies developing drugs in the complex areas of neurology, psychiatry, pain and cancer research. We also offer specialized pediatric drug development expertise across all therapeutic areas.

Therapeutic Expertise - High Performance Teams
Our team is built from the brightest people in the industry with years of Central Nervous System (CNS), Oncology, and industry-related experience, from our top scientists to our data entry group. We proactively seek out the top talent in the industry. It is by continually attracting the industry's most talented individuals that INC Research has emerged as a leading global CRO. Our high percentage of repeat business from customers is a testament to the quality and dedication of our INC Research team. We invite you to inquire about being a member of this group of top-notch professionals.

Customized Service - Flexible Approach
A customer-centric focus is a clear, common objective across our entire organization. We tailor our full range of services, processes and technology to the unique needs of each client and their specific project requirements. For Phase I-IV clinical trials, we provide:

  • Scientific, Medical & Regulatory Consulting
  • Cognitive Services
  • Pediatric Services
  • Study Monitoring
  • Project Management
  • Medical Monitoring & Drug Safety
  • Data Management
  • Biostatistics
  • Medical Writing
  • Quality Assurance

    We take a highly flexible, customized approach to clinical research. By listening closely to our customers, we can tailor our services to the unique needs of each client and each project. Whether the scope of your project is a full-service international study or requires only select regional services, INC Research can meet your needs.

    Global Presence
    With a presence in 32 countries worldwide, we can deploy our services anywhere, on any scale.

    Key Contacts:
    For general company information, contact Trisha Vonder Reith, Executive Director Corporate Communications & Marketing at:

    To learn more about career opportunities, please contact Karen Thomson, Manager of Recruiting at:

    Last Updated: 09-30-05

    Key Statistics

    Ownership: Public

    Web Site: INC Research
    Symbol: INCR

  • Industry

    Company News
    INC Research (INCR) Appoints William E. Klitgaard And Linda S. Harty To Board Of Directors 3/3/2017 8:57:06 AM
    Medidata Solutions, Inc. And INC Research (INCR) Expand Technology Partnership 3/2/2017 7:13:19 AM
    INC Research (INCR) Reports Fourth Quarter And Full Year 2016 Results 2/28/2017 8:17:54 AM
    INC Research (INCR) Expands Functional Service Provider Services Through New Investigator Payment Offering 2/23/2017 11:24:19 AM
    INC Research (INCR) Further Strengthens Board Of Directors Through Appointment Of Pharmaceutical Executive Eric P. Pâques 2/9/2017 8:31:32 AM
    INC Research (INCR) Schedules Fourth Quarter And Year End 2016 Earnings Call For Tuesday, February 28, 2017 2/7/2017 11:00:55 AM
    INC Research (INCR) Creating 550 New Jobs in HQ Move 12/14/2016 5:36:23 AM
    Cellectar Biosciences  (CLRB) Announces INC Research (INCR) As The CRO For The Phase II Trial Of CLR 131 In Hematologic Malignancies; $2 Million NCI Grant Covers Half Of Study Cost, With Potential Option To Pursue Additional $3 Million For Pivotal Trial 11/15/2016 8:34:35 AM
    INC Research (INCR) Selected To Manage The Leukemia & Lymphoma Society’s First-Ever Master Trial To Advance New Targeted Therapies For Acute Myeloid Leukemia 11/8/2016 8:12:18 AM
    INC Research (INCR) Reports Third Quarter 2016 Results 10/31/2016 8:10:21 AM